Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
We have previously reported suggestive linkage of type 2 diabetes mellitus to chromosome 10q. We genotyped 228 microsatellite markers in Icelandic individuals with type 2 diabetes and controls throughout a 10.5-Mb interval on 10q. A microsatellite, DG10S478, within intron 3 of the transcription factor 7-like 2 gene (TCF7L2; formerly TCF4) was associated with type 2 diabetes (P = 2.1 x 10(-9)). This was replicated in a Danish cohort (P = 4.8 x 10(-3)) and in a US cohort (P = 3.3 x 10(-9)). Compared with non-carriers, heterozygous and homozygous carriers of the at-risk alleles (38% and 7% of the population, respectively) have relative risks of 1.45 and 2.41. This corresponds to a population attributable risk of 21%. The TCF7L2 gene product is a high mobility group box-containing transcription factor previously implicated in blood glucose homeostasis. It is thought to act through regulation of proglucagon gene expression in enteroendocrine cells via the Wnt signaling pathway.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The majority of associated loci are linked to beta cells, supporting the idea that impaired beta cell function is critical to type 2 diabetes pathogenesis78,80.”
From 100 years of insulin: celebrating the past, present and future of diabetes therapy (2021) · cites this paper as [78]
In the citing paper
“The first associated loci, in genes including TCF7L2, INSR, IRS1, GCK and KCNJ11 (refs.77,78), were originally identified by linkage or candidate gene studies, and since the turn of the century, increasing size and depth of genome-wide association studies have rapidly expanded the list of associated loci in type 2 diabetes to more than 250 with 400 independent signals79.”
From 100 years of insulin: celebrating the past, present and future of diabetes therapy (2021) · cites this paper as [78]
In the citing paper
“unequivocal replications are so far limited to variants in just three genes: PPARG, KCNJ11 and TCF7L2 (2-4).”
From Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes (2007) · cites this paper as [4]
Citations
Cites
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
The International HapMap Project
†The International HapMap Consortium, Genotyping centres: Baylor College of Medicine and ParAllele BioScience, Gibbs, R. A., Belmont, J. W., Hardenbol, P., Willis, T. D., Yu, F., Chinese HapMap Consortium, Yang, H., Ch'ang, L.-Y., et al. (2003) · Nature · doi:10.1038/nature02168 · Cited by 6,057
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883 · cited 1×
“The prevalence of type 2 diabetes worldwide is 6% but is projected to rise over the next decade owing to increasing age of the population and surge of obesit”
BackgroundConvergence of Wnt, ß-Catenin, and Cadherin Pathways
Nelson, W. J., & Nusse, R. (2004) · Science · doi:10.1126/science.1094291 · Cited by 2,515 · cited 1×
“The β-catenin protein is also important for mediating cell adhesion through its binding of cadherin”
BackgroundThe common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
Altshuler, D., Hirschhorn, J. N., Klannemark, M., Lindgren, C. M., Vohl, M.-C., Nemesh, J., Lane, C. R., Schaffner, S. F., Bolk, S., Brewer, C., et al. (2000) · Nature Genetics · doi:10.1038/79216 · Cited by 1,766
Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4
Korinek, V., Barker, N., Moerer, P., van Donselaar, E., Huls, G., Peters, P. J., & Clevers, H. (1998) · Nature Genetics · doi:10.1038/1270 · Cited by 1,581
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus
Horikawa, Y., Oda, N., Cox, N. J., Li, X., Orho-Melander, M., Hara, M., Hinokio, Y., Lindner, T. H., Mashima, H., Schwarz, P. E. H., et al. (2000) · Nature Genetics · doi:10.1038/79876 · Cited by 1,468
Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young
Fajans, S. S., Bell, G. I., & Polonsky, K. S. (2001) · New England Journal of Medicine · doi:10.1056/nejmra002168 · Cited by 1,123 · cited 1×
“Similar to TCF7L2 , five of the six positionally cloned genes for the rare mendelian forms of type 2 diabetes, maturity-onset diabetes of the young (MODY), are transcription factor”
BackgroundAllele-Sharing Models: LOD Scores and Accurate Linkage Tests
Kong, A., & Cox, N. J. (1997) · The American Journal of Human Genetics · doi:10.1086/301592 · Cited by 979
Self-citationGloyn, A. L., Weedon, M. N., Owen, K. R., Turner, M. J., Knight, B. A., Hitman, G., Walker, M., Levy, J. C., Sampson, M., Halford, S., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.2.568 · Cited by 754
Cited by
Items 101–200 of 1,004
Omori, S., Tanaka, Y., Takahashi, A., Hirose, H., Kashiwagi, A., Kaku, K., Kawamori, R., Nakamura, Y., & Maeda, S. (2008) · Diabetes · doi:10.2337/db07-0979 · Cited by 280
“0777 rs1801282 CC (2) CG (53) GG (995) PPARG Pro12Ala 24.”
BackgroundChandak, G. R., Janipalli, C. S., Bhaskar, S., Kulkarni, S. R., Mohankrishna, P., Hattersley, A. T., Frayling, T. M., & Yajnik, C. S. (2006) · Diabetologia · doi:10.1007/s00125-006-0502-2 · Cited by 279
“We found a strong association of TCF7L2 variants with type 2 diabetes mellitus in this Indian population, replicating observations in European populations [10, 11].”
BackgroundResultInfluentialDamcott, C. M., Pollin, T. I., Reinhart, L. J., Ott, S. H., Shen, H., Silver, K. D., Mitchell, B. D., & Shuldiner, A. R. (2006) · Diabetes · doi:10.2337/db06-0338 · Cited by 277
“(5) put forth the hypothesis that variants in TCF7L2 influence type 2 diabetes susceptibility through altered transcriptional regulation of the insulinotropic hormone glucagon-like peptide-1 (GLP1), a peptide encoded by GCG and expressed in the brain and gut.”
BackgroundMethodInfluentialModifier genes in Mendelian disorders: the example of cystic fibrosis
Cutting, G. R. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05879.x · Cited by 271
Adult-onset autoimmune diabetes: current knowledge and implications for management
Buzzetti, R., Zampetti, S., & Maddaloni, E. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.99 · Cited by 271
“Furthermore, a new autoantibody against the extracytoplasmatic (EC) IA-2EC(26-577) region can identify a novel antigenic determinant within the N terminus of the IA-2 protein76.”
BackgroundA Critical Role for the Wnt Effector Tcf4 in Adult Intestinal Homeostatic Self-Renewal
van Es, J. H., Haegebarth, A., Kujala, P., Itzkovitz, S., Koo, B.-K., Boj, S. F., Korving, J., van den Born, M., van Oudenaarden, A., Robine, S., et al. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06288-11 · Cited by 276
“The newly generated floxed Tcf4 allele may be instrumental to study the role of Tcf4 in (intestinal) tumorigenesis and diabetes (14).”
Background100 years of insulin: celebrating the past, present and future of diabetes therapy
Sims, E. K., Carr, A. L. J., Oram, R. A., DiMeglio, L. A., & Evans-Molina, C. (2021) · Nature Medicine · doi:10.1038/s41591-021-01418-2 · Cited by 270
Shu, L., Matveyenko, A. V., Kerr-Conte, J., Cho, J.-H., McIntosh, C. H. S., & Maedler, K. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp178 · Cited by 270
“Recent results from genome-wide association studies revealed new gene mutations in T2DM (29).”
BackgroundResultLarge-Scale Gene-Centric Meta-Analysis across 39 Studies Identifies Type 2 Diabetes Loci
Saxena, R., Elbers, C. C., Guo, Y., Peter, I., Gaunt, T. R., Mega, J. L., Lanktree, M. B., Tare, A., Castillo, B. A., Li, Y. R., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.12.022 · Cited by 270
Self-citationAdaptations to Climate in Candidate Genes for Common Metabolic Disorders
Hancock, A. M., Witonsky, D. B., Gordon, A. S., Eshel, G., Pritchard, J. K., Coop, G., & Di Rienzo, A. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.0040032 · Cited by 272
“The TCF7L2 gene, which shows the strongest signals in genome-wide association studies of T2D [60–64], harbors several SNPs with strong climate signals; as for RAPTOR, no common nonsynonymous SNPs are known at this gene [65].”
BackgroundCombining Information from Common Type 2 Diabetes Risk Polymorphisms Improves Disease Prediction
Weedon, M. N., McCarthy, M. I., Hitman, G., Walker, M., Groves, C. J., Zeggini, E., Rayner, N. W., Shields, B., Owen, K. R., Hattersley, A. T., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030374 · Cited by 268
“Using this definition, alleles of PPARG (Pro12) [11], KCNJ11 (Lys23) [12–14], and TCF7L2 (T at rs7903146) [15] have been reproducibly associated with type 2 diabetes.”
BackgroundYamauchi, T., Hara, K., Maeda, S., Yasuda, K., Takahashi, A., Horikoshi, M., Nakamura, M., Fujita, H., Grarup, N., Cauchi, S., et al. (2010) · Nature Genetics · doi:10.1038/ng.660 · Cited by 270
Transcription Factor 7-Like 2 Regulates β-Cell Survival and Function in Human Pancreatic Islets
Shu, L., Sauter, N. S., Schulthess, F. T., Matveyenko, A. V., Oberholzer, J., & Maedler, K. (2008) · Diabetes · doi:10.2337/db07-0847 · Cited by 265
“(4) reported linkage between a variant of the transcription factor 7-like 2 (TCF7L2) and type 2 diabetes in Danish and U.”
BackgroundMethodRetractedTong, Y., Lin, Y., Zhang, Y., Yang, J., Zhang, Y., Liu, H., & Zhang, B. (2009) · BMC Medical Genetics · doi:10.1186/1471-2350-10-15 · Cited by 262
“Recent years, some novel loci in genes such as TCF7L2, SLC30A8, HHEX, ETX2, CDKN2A/CDKN2B, IGF2BP2, CDKAL1, FTO, PPARG, and KCNJ11 have been found with susceptibility to T2DM [2,73-76], and these has promoted the development of genetics on T2DM.”
InfluentialWelt, C. K., Gudmundsson, J. A., Arason, G., Adams, J., Palsdottir, H., Gudlaugsdottir, G., Ingadottir, G., & Crowley, W. F. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1327 · Cited by 261
“The definition of these PCOS subsets is especially timely because the resulting phenotypes may have implications for the genetic searches that they presage now that the tools are in place to determine the gene(s) underlying this polygenic condition (5, 6).”
BackgroundBurton, P. R., Hansell, A. L., Fortier, I., Manolio, T. A., Khoury, M. J., Little, J., & Elliott, P. (2009) · International Journal of Epidemiology · doi:10.1093/ije/dyn147 · Cited by 258
Wnt signaling regulates mitochondrial physiology and insulin sensitivity
Yoon, J. C., Ng, A., Kim, B. H., Bianco, A., Xavier, R. J., & Elledge, S. J. (2010) · Genes & Development · doi:10.1101/gad.1924910 · Cited by 257
Type 2 diabetes: new genes, new understanding
Prokopenko, I., McCarthy, M. I., & Lindgren, C. M. (2008) · Trends in Genetics · doi:10.1016/j.tig.2008.09.004 · Cited by 254
Ioannidis, J. P. A. (2011) · JAMA · doi:10.1001/jama.2011.713 · Cited by 252
Groves, C. J., Zeggini, E., Minton, J., Frayling, T. M., Weedon, M. N., Rayner, N. W., Hitman, G. A., Walker, M., Wiltshire, S., Hattersley, A. T., et al. (2006) · Diabetes · doi:10.2337/db06-0355 · Cited by 252
“The present study does not contribute to efforts to specify which TCF7L2 variants are etiological; it is likely that the SNPs typed here are not causal (6).”
BackgroundInfluentialGenetic Architecture of Insulin Resistance in the Mouse
Parks, B. W., Sallam, T., Mehrabian, M., Psychogios, N., Hui, S. T., Norheim, F., Castellani, L. W., Rau, C. D., Pan, C., Phun, J., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.01.002 · Cited by 249
“Genetic studies in humans have been successful at identifying genetic loci associated with T2D and other related traits, including obesity and plasma lipid levels (Grant et al., 2006; Scott et al., 2012; Sladek et al., 2007; Speliotes et al., 2010; Teslovich et al., 2010).”
BackgroundGenetic Background Limits Generalizability of Genotype-Phenotype Relationships
Sittig, L. J., Carbonetto, P., Engel, K. A., Krauss, K. S., Barrios-Camacho, C. M., & Palmer, A. A. (2016) · Neuron · doi:10.1016/j.neuron.2016.08.013 · Cited by 249
Aguayo‐Mazzucato, C., Diaque, P., Hernandez, S., Rosas, S., Kostic, A., & Caballero, A. E. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3097 · Cited by 246
Cho, Y. M., Kim, T. H., Lim, S., Choi, S. H., Shin, H. D., Lee, H. K., Park, K. S., & Jang, H. C. (2009) · Diabetologia · doi:10.1007/s00125-008-1196-4 · Cited by 243
“Except for the effects of TCF7L2 in Scandinavian women [17], no robust associations of genetic variants with GDM have been demonstrated.”
BackgroundInfluentialCase–control association mapping by proxy using family history of disease
Liu, J. Z., Erlich, Y., & Pickrell, J. K. (2017) · Nature Genetics · doi:10.1038/ng.3766 · Cited by 238
Reduced insulin exocytosis in human pancreatic β-cells with gene variants linked to type 2 diabetes
Rosengren, A. H., Braun, M., Mahdi, T., Andersson, S. A., Travers, M. E., Shigeto, M., Zhang, E., Almgren, P., Ladenvall, C., Axelsson, A. S., et al. (2012) · Diabetes · doi:10.2337/db11-1516 · Cited by 237
“Human islets from donors with the TCF7L2 rs7903146 risk genotype, the genetic variant with the largest effect on T2D susceptibility known to date (20,21), displayed significantly reduced insulin secretion (P = 0.”
BackgroundScott, L. J., Bonnycastle, L. L., Willer, C. J., Sprau, A. G., Jackson, A. U., Narisu, N., Duren, W. L., Chines, P. S., Stringham, H. M., Erdos, M. R., et al. (2006) · Diabetes · doi:10.2337/db06-0341 · Cited by 236
“95) with the most strongly associated DG10S478 allele and, therefore, also with the combined risk allele (2).”
BackgroundInfluentialSubtypes of Type 2 Diabetes Determined From Clinical Parameters
Ahlqvist, E., Prasad, R. B., & Groop, L. (2020) · Diabetes · doi:10.2337/dbi20-0001 · Cited by 229
“Genetically, SIRD stands out by neither being associated with the well-established T2D locus in TCF7L2 (26,27) nor”
BackgroundBoj, S. F., van Es, J. H., Huch, M., Li, V. S. W., José, A., Hatzis, P., Mokry, M., Haegebarth, A., van den Born, M., Chambon, P., et al. (2012) · Cell · doi:10.1016/j.cell.2012.10.053 · Cited by 237
“Grant and colleagues identified a strong association between T2D risk and intronic SNPs in TCF7L2 (Grant et al., 2006).”
BackgroundThe Spectrum of Achalasia: Lessons From Studies of Pathophysiology and High-Resolution Manometry
Kahrilas, P. J., & Boeckxstaens, G. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.038 · Cited by 235
Genome-wide association studies in type 2 diabetes
McCarthy, M. I., & Zeggini, E. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0027-4 · Cited by 233
“This locus was unearthed after a linkage peak fi ne-mapping study on chromosome 10 [ 11 ].”
BackgroundUnimolecular Polypharmacy for Treatment of Diabetes and Obesity
Tschöp, M. H., Finan, B., Clemmensen, C., Gelfanov, V., Perez-Tilve, D., Müller, T. D., & DiMarchi, R. D. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.06.021 · Cited by 235
Obesity, unfavourable lifestyle and genetic risk of type 2 diabetes: a case-cohort study
Schnurr, T. M., Jakupović, H., Carrasquilla, G. D., Ängquist, L., Grarup, N., Sørensen, T. I. A., Tjønneland, A., Overvad, K., Pedersen, O., Hansen, T., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05140-5 · Cited by 231
Cervin, C., Lyssenko, V., Bakhtadze, E., Lindholm, E., Nilsson, P., Tuomi, T., Cilio, C. M., & Groop, L. (2008) · Diabetes · doi:10.2337/db07-0299 · Cited by 230
“However, recently, variation in the transcription factor 7-like 2 (TCF7L2) gene showed strong association with type 2 diabetes (10,11), making this gene a good candidate for genetic comparisons between LADA and type 2 diabetes.”
BackgroundTumour necrosis factor-α inhibits adipogenesis via a β-catenin/TCF4(TCF7L2)-dependent pathway
Cawthorn, W. P., Heyd, F., Hegyi, K., & Sethi, J. K. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402127 · Cited by 231
“Furthermore, recent studies have identified a strong association between at least 2 SNPS in the TCF7L2 gene and type II diabetes.(34) However, these risk-conferring genotypes are not associated with insulin resistance but rather with impaired b-cell function, development and possibly survival.”
Diabetic kidney diseases revisited: A new perspective for a new era
Fu, H., Liu, S., Bastacky, S. I., Wang, X., Tian, X.-J., & Zhou, D. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.10.005 · Cited by 226
“In early years, linkage analyses and candidate gene screen indeed identified a few T2DM risk genes, such as calpain 10 [79], transcription factor 7-like 2 [80], peroxisome proliferator-activated receptor gamma [81], insulin receptor substrate 1 [82,83], and angiotensin-converting enzyme [84,85].”
BackgroundCommon Type 2 Diabetes Risk Gene Variants Associate with Gestational Diabetes
Lauenborg, J., Grarup, N., Damm, P., Borch-Johnsen, K., Jørgensen, T., Pedersen, O., & Hansen, T. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1336 · Cited by 227
Serre, D., Gurd, S., Ge, B., Sladek, R., Sinnett, D., Harmsen, E., Bibikova, M., Chudin, E., Barker, D. L., Dickinson, T., et al. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000006 · Cited by 226
“[5–7]) or far away from any annotated loci (e.”
BackgroundThe role of FOXO1 in β-cell failure and type 2 diabetes mellitus
Kitamura, T. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.157 · Cited by 221
CREB and FoxO1: two transcription factors for the regulation of hepatic gluconeogenesis
Oh, K.-J., Han, H.-S., Kim, M.-J., & Koo, S.-H. (2013) · BMB Reports · doi:10.5483/bmbrep.2013.46.12.248 · Cited by 222
“with increases in the incidence of this disease (80-84).”
BackgroundThe Genetic Landscape of Type 2 Diabetes in Mice
Clee, S. M., & Attie, A. D. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0035 · Cited by 220
“The assembly of very large, well-defined cohorts and collaborative efforts among multiple groups will also aid these efforts and, indeed, is already yielding success (26).”
BackgroundGlucagon-Like Peptide 1 Secretion by the L-Cell
Lim, G. E., & Brubaker, P. L. (2006) · Diabetes · doi:10.2337/db06-s020 · Cited by 223
“Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic”
BackgroundInfluentialNg, L., Kaur, P., Bunnag, N., Suresh, J., Sung, I., Tan, Q., Gruber, J., & Tolwinski, N. (2019) · Cells · doi:10.3390/cells8080826 · Cited by 212
Perry, J. R. B., Weedon, M. N., Langenberg, C., Jackson, A. U., Lyssenko, V., Sparsø, T., Thorleifsson, G., Grallert, H., Ferrucci, L., Maggio, M., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddp522 · Cited by 217
“39, are similar to those for SNPs in the TCF7L2 gene (9), which raises doubt as to why these associations were not found by genome-wide association approaches, and the evidence of association between SHBG SNPs and type 2 diabetes was not strong (P 1⁄4 0.”
BackgroundTCF7L2 is a master regulator of insulin production and processing
Zhou, Y., Park, S.-Y., Su, J., Bailey, K., Ottosson-Laakso, E., Shcherbina, L., Oskolkov, N., Zhang, E., Thevenin, T., Fadista, J., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu359 · Cited by 218
Redondo, M. J., Steck, A. K., & Pugliese, A. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12597 · Cited by 216
“Genetic variants in the transcription factor 7 like-2 (TCF7L2) locus are the strongest genetic factor in T2D.89 Although this locus is not associated with T1D over- all, individuals with T1D with milder autoimmunity, as suggested by the expression of single islet autoantibody and/or absence of high risk HLA types, are…”
BackgroundLi, Y. R., & Keating, B. J. (2014) · Genome Medicine · doi:10.1186/s13073-014-0091-5 · Cited by 214
“Type 2 diabetes TCF7L2 Haplotype analysis Replication of primary signal in WA population and fine-mapping of second independent signal showing positive selection in WA, EA and EUR cohorts; recently also replicated in large-scale meta-analysis over 39 studies [42,105]”
The genetic and epigenetic basis of type 2 diabetes and obesity
Drong, A. W., Lindgren, C. M., & McCarthy, M. I. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.149 · Cited by 212
Horikoshi, M., Hara, K., Ito, C., Shojima, N., Nagai, R., Ueki, K., Froguel, P., & Kadowaki, T. (2007) · Diabetologia · doi:10.1007/s00125-007-0827-5 · Cited by 214
“Indeed, since the original discovery of the powerful type 2 diabetes gene, transcription factor 7-like 2 (T cell specific, HMGbox) (TCF7L2), by a joint group from Iceland, the USA and Denmark [1], many groups have confirmed the significant association between type 2 diabetes and this gene in several populations [2–4].”
BackgroundThe Epigenetic Basis of Twin Discordance in Age-Related Diseases
Poulsen, P., Esteller, M., Vaag, A., & Fraga, M. F. (2007) · Pediatric Research · doi:10.1203/pdr.0b013e31803c7b98 · Cited by 213
“However, some studies have demonstrated associations between various metabolic defects underlying the development of type 2 diabetes and polymorphisms in several susceptibility genes, such as PPAR (6), PGC-1 (7), and, most recently, TCF7L2 (8).”
Wnt Signaling in vascular eye diseases
Wang, Z., Liu, C.-H., Huang, S., & Chen, J. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.11.008 · Cited by 211
Genomics and Genetics in the Biology of Adaptation to Exercise
Bouchard, C., Rankinen, T., & Timmons, J. A. (2011) · Comprehensive Physiology · doi:10.1002/cphy.c100059 · Cited by 136
The Role of TCF7L2 in Type 2 Diabetes
del Bosque-Plata, L., Martínez-Martínez, E., Espinoza-Camacho, M. Á., & Gragnoli, C. (2021) · Diabetes · doi:10.2337/db20-0573 · Cited by 202
“4, were the single nucleotide polymorphisms (SNPs) rs7903146 and rs12255372, in strong LD with the microsatellite marker DG10S478, whereas alleles rs7903146-T and rs12255372-T showed the most statistically significant association with T2D (1).”
BackgroundThe WNT signalling pathway and diabetes mellitus
Jin, T. (2008) · Diabetologia · doi:10.1007/s00125-008-1084-y · Cited by 207
“The investigators found that two of five SNPs investigated within introns 4 and 5 of TCF7L2, namely rs12255372 and rs7903146, were in strong linkage disequilibrium with DG10S478 and showed similarly robust associations with type 2 diabetes [ 20 ].”
BackgroundResultInfluentialThe HapMap and Genome-Wide Association Studies in Diagnosis and Therapy
Manolio, T. A., & Collins, F. S. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.60.061907.093117 · Cited by 207
TCF7L2 Regulates Late Events in Insulin Secretion From Pancreatic Islet β-Cells
da Silva Xavier, G., Loder, M. K., McDonald, A., Tarasov, A. I., Carzaniga, R., Kronenberger, K., Barg, S., & Rutter, G. A. (2009) · Diabetes · doi:10.2337/db08-1187 · Cited by 207
“These, and an earlier candidate gene study (11), identified single nucleotide polymorphisms (SNPs), including SNP rs7903146, in the third intron of the gene encoding transcription factor 7-like 2 (TCF7L2; also known as transcription factor 4) as strongly associated with type 2 diabetes in different ethnic backgrounds…”
BackgroundZhang, C., Qi, L., Hunter, D. J., Meigs, J. B., Manson, J. E., van Dam, R. M., & Hu, F. B. (2006) · Diabetes · doi:10.2337/db06-0643 · Cited by 204
“Most recently, within a region in linkage to type 2 diabetes on chromosome 10q (4,5), a set of single nucleotide polymorphisms (SNPs) and a microsatellite marker in a well-defined linkage disequilibrium (LD) block in the transcription factor 7-like 2 (TCF7L2) gene were found to be significantly associated with type 2…”
BackgroundResultInfluentialGenetics of obesity and the prediction of risk for health
Walley, A. J., Blakemore, A. I. F., & Froguel, P. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl215 · Cited by 204
“Researchers in the field of complex human genetics are increasingly aware of these problems and examples such as the TCF7L2 association with diabetes (32) demonstrate that sufficiently powerful studies can generate statistically strong results (P , 10(28)).”
BackgroundGrarup, N., Sandholt, C. H., Hansen, T., & Pedersen, O. (2014) · Diabetologia · doi:10.1007/s00125-014-3270-4 · Cited by 201
“The risk variant in the TCF7L2 locus, which was discovered in 2006 by a positional linkage strategy in the Icelandic population [26], remains the most influential common type 2 diabetes variant (allelic OR ~1.”
BackgroundDayeh, T. A., Olsson, A. H., Volkov, P., Almgren, P., Rönn, T., & Ling, C. (2013) · Diabetologia · doi:10.1007/s00125-012-2815-7 · Cited by 199
“SNPs within TCF7L2 confer the highest genetic risk of developing type 2 diabetes [21, 24, 43 – 45].”
Grant, S. F. A., Li, M., Bradfield, J. P., Kim, C. E., Annaiah, K., Santa, E., Glessner, J. T., Casalunovo, T., Frackelton, E. C., Otieno, F. G., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001746 · Cited by 202
“Recently, a number of studies have reported remarkably strong, replicable associations with complex disease, including the complement factor H (CFH) gene in age-related macular degeneration[24,25,26] and the transcription factor 7-like-2 (TCF7L2) gene in type 2 diabetes[27,28,29].”
BackgroundSelf-citationType 2 Diabetes Whole-Genome Association Study in Four Populations: The DiaGen Consortium
Salonen, J. T., Uimari, P., Aalto, J.-M., Pirskanen, M., Kaikkonen, J., Todorova, B., Hyppönen, J., Korhonen, V.-P., Asikainen, J., Devine, C., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/520599 · Cited by 196
Mahdi, T., Hänzelmann, S., Salehi, A., Muhammed, S. J., Reinbothe, T. M., Tang, Y., Axelsson, A. S., Zhou, Y., Jing, X., Almgren, P., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.10.009 · Cited by 193
“, 2008), including the Wnt effector TCF7L2 (da Silva Xavier et al., 2009; Grant et al., 2006).”
InfluentialMoving toward a system genetics view of disease
Sieberts, S. K., & Schadt, E. E. (2007) · Mammalian Genome · doi:10.1007/s00335-007-9040-6 · Cited by 194
“Because it is also now possible to monitor transcript levels in a comprehensive fashion, integrating DNA variation, transcription, and phenotypic data has the potential to enhance identification of the associations between DNA variation and diseases like obesity and diabetes, as well as…”
BackgroundMalakar, P., Stein, I., Saragovi, A., Winkler, R., Stern-Ginossar, N., Berger, M., Pikarsky, E., & Karni, R. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-1432 · Cited by 188
Waters, K. M., Stram, D. O., Hassanein, M. T., Le Marchand, L., Wilkens, L. R., Maskarinec, G., Monroe, K. R., Kolonel, L. N., Altshuler, D., Henderson, B. E., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001078 · Cited by 191
“With the exception of the KCNQ1 locus which was identified in the Japanese population [1,2], all of the well-replicated risk variants were first identified in populations of Northern European ancestry [3–13].”
BackgroundAbnormalities in insulin secretion in type 2 diabetes mellitus
Guillausseau, P.-J., Meas, T., Virally, M., Laloi-Michelin, M., Médeau, V., & Kevorkian, J.-P. (2008) · Diabetes & Metabolism · doi:10.1016/s1262-3636(08)73394-9 · Cited by 190
“Recently, a major type 2 diabetes susceptibility gene, accounting for 20% of cases, TCF7L2, has been identified by Grant et al in Icelanders [53].”
Chang, Y.-C., Chang, T.-J., Jiang, Y.-D., Kuo, S.-S., Lee, K.-C., Chiu, K. C., & Chuang, L.-M. (2007) · Diabetes · doi:10.2337/db07-0421 · Cited by 191
“41 in heterozygous and homozygous carriers (6) and the diabetes prevalence of 8 % in the Chinese population in Taiwan, enrollment of approximately 1,700 cases would be necessary for the case-control study to have 80 percent power (32).”
BackgroundResultInfluentialT-cell factor 4 and β-catenin chromatin occupancies pattern zonal liver metabolism in mice
Gougelet, A., Torre, C., Veber, P., Sartor, C., Bachelot, L., Denechaud, P.-D., Godard, C., Moldes, M., Burnol, A.-F., Dubuquoy, C., et al. (2014) · Hepatology · doi:10.1002/hep.26924 · Cited by 190
“The strong effect that Tcf4/b-catenin exerts on metabolic genes can partly explain why Tcf-4 (TCF7L2 gene) is a type 2 diabetes gene candidate in humans.(32) Recently, it has been shown that this role for TCF7L2 is related to its hepatic expression.”
BackgroundMinireview: The Wnt Signaling Pathway Effector TCF7L2 and Type 2 Diabetes Mellitus
Jin, T., & Liu, L. (2008) · Molecular Endocrinology · doi:10.1210/me.2008-0135 · Cited by 188
Genome-wide association scans identified CTNNBL1 as a novel gene for obesity
Liu, Y.-J., Liu, X.-G., Wang, L., Dina, C., Yan, H., Liu, J.-F., Levy, S., Papasian, C. J., Drees, B. M., Hamilton, J. J., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn072 · Cited by 187
Mechanistic Insights Into Diabetes Mellitus and Oxidative Stress
Maiese, K., Chong, Z. Z., & Shang, Y. C. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707781058968 · Cited by 186
The genetics of the polycystic ovary syndrome
Urbanek, M. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0400 · Cited by 185
Chauhan, G., Spurgeon, C. J., Tabassum, R., Bhaskar, S., Kulkarni, S. R., Mahajan, A., Chavali, S., Kumar, M. V. K., Prakash, S., Dwivedi, O. P., et al. (2010) · Diabetes · doi:10.2337/db09-1386 · Cited by 185
“Until recently, only a few common variants in PPARG (3), KCNJ11 (4), and TCF7L2 (5) were shown to be associated with type 2 diabetes.”
Xia, Q., & Grant, S. F. A. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12020 · Cited by 174
Self-citationPhysiology of incretins (GIP and GLP-1) and abnormalities in type 2 diabetes
Gautier, J.-F., Choukem, S.-P., & Girard, J. (2008) · Diabetes & Metabolism · doi:10.1016/s1262-3636(08)73397-4 · Cited by 183
“Variants of TCF7L2 have been reproducibly shown to be strongly associated with type 2 diabetes and impaired insulin secretion in various populations [53-55].”
Nebert, D. W., Zhang, G., & Vesell, E. S. (2008) · Drug Metabolism Reviews · doi:10.1080/03602530801952864 · Cited by 181
Nutrigenetics and Metabolic Disease: Current Status and Implications for Personalised Nutrition
Phillips, C. (2013) · Nutrients · doi:10.3390/nu5010032 · Cited by 178
“Two novel single nucleotide polymorphisms (SNP) in the Wnt signaling regulated TCF7L2 gene were associated with increased T2DM risk [47,48], most likely through defective beta-cell function and impaired insulin secretion [47].”
BackgroundSclerostin influences body composition by regulating catabolic and anabolic metabolism in adipocytes
Kim, S. P., Frey, J. L., Li, Z., Kushwaha, P., Zoch, M. L., Tomlinson, R. E., Da, H., Aja, S., Noh, H. L., Kim, J. K., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1707876115 · Cited by 176
Statistical false positive or true disease pathway?
Todd, J. A. (2006) · Nature Genetics · doi:10.1038/ng0706-731 · Cited by 180
Wang, J., Kuusisto, J., Vänttinen, M., Kuulasmaa, T., Lindström, J., Tuomilehto, J., Uusitupa, M., & Laakso, M. (2007) · Diabetologia · doi:10.1007/s00125-007-0656-6 · Cited by 178
“In addition, and similarly to the findings of other studies [1, 2], we also found that the T allele of rs12255372 and rs7903146 was significantly associated with lower BMI in Study III.”
BackgroundResultThe role of the p53 tumor suppressor in metabolism and diabetes
Kung, C.-P., & Murphy, M. E. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0324 · Cited by 178
Designing candidate gene and genome-wide case–control association studies
Zondervan, K. T., & Cardon, L. R. (2007) · Nature Protocols · doi:10.1038/nprot.2007.366 · Cited by 178
“Other common variants that have been recently identified include TCF7L”
BackgroundTsatsoulis, A., Mantzaris, M. D., Bellou, S., & Andrikoula, M. (2013) · Metabolism · doi:10.1016/j.metabol.2012.11.004 · Cited by 174
“[100] Grant SF, Thorleifsson G, Reynisdottir I, et al.”
BackgroundGenetics of type 2 diabetes: pathophysiologic and clinical relevance
Herder, C., & Roden, M. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02454.x · Cited by 175
Pharmacogenetics in drug discovery and development: a translational perspective
Roses, A. D. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2593 · Cited by 174
Okamura, M., Kudo, H., Wakabayashi, K.-I., Tanaka, T., Nonaka, A., Uchida, A., Tsutsumi, S., Sakakibara, I., Naito, M., Osborne, T. F., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901676106 · Cited by 178
“We and others have reported that proteins involved in the Wnt signal cascade including the Wnt coreceptors LRP5 and LRP6 and its nuclear effector protein TCF7L2 are linked to type 2 diabetes (3, 17).”
BackgroundLee, Y.-H., Kang, E. S., Kim, S. H., Han, S. J., Kim, C. H., Kim, H. J., Ahn, C. W., Cha, B. S., Nam, M., Nam, C. M., et al. (2008) · Journal of Human Genetics · doi:10.1007/s10038-008-0341-8 · Cited by 177
Wnt Signaling Regulates Hepatic Metabolism
Liu, H., Fergusson, M. M., Wu, J. J., Rovira, I. I., Liu, J., Gavrilova, O., Lu, T., Bao, J., Han, D., Sack, M. N., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001249 · Cited by 174
“Although considerable caution regarding causality must be applied to any genetic association study, these observations are at least provocative as to how variations in TCF7L2 might contribute to diabetes (7).”
BackgroundGenetic susceptibility to myocardial infarction and coronary artery disease
Topol, E. J., Smith, J., Plow, E. F., & Wang, Q. K. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl183 · Cited by 173
“Although we are still in the early phase of understanding the genomic basis of complex traits, there have been some remarkable recent advances for disease such as AMD (1–3), inflammatory bowel disease (4) and diabetes (5).”
BackgroundThe Wnt signaling pathway: Aging gracefully as a protectionist?
Maiese, K., Li, F., Chong, Z. Z., & Shang, Y. C. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.01.004 · Cited by 170
Genetic variants and the metabolic syndrome: a systematic review
Povel, C. M., Boer, J. M. A., Reiling, E., & Feskens, E. J. M. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00907.x · Cited by 169
“The T allele of the rs7903146 polymorphism in the TCF7L2 gene increases the risk of T2D (50).”
BackgroundInfluentialGonzález, N., Diabetes Cancer Connect Consortium, Prieto, I., del Puerto-Nevado, L., Portal-Nuñez, S., Ardura, J. A., Corton, M., Fernández-Fernández, B., Aguilera, O., Gomez-Guerrero, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14472 · Cited by 168
“TCF7L2 harbors common genetic variants with the strongest effect on T2DM risk [157-159] and on DM complications such as DKD [160] and is also susceptibility locus for CRC loci in East Asians [161].”
BackgroundTCF7L2 Polymorphisms Modulate Proinsulin Levels and β-Cell Function in a British Europid Population
Loos, R. J. F., Franks, P. W., Francis, R. W., Barroso, I., Gribble, F. M., Savage, D. B., Ong, K. K., O'Rahilly, S., & Wareham, N. J. (2007) · Diabetes · doi:10.2337/db07-0055 · Cited by 169
“27 in homozygotes in an Icelandic population, a finding that was replicated in a Danish and a European-American population (1).”
ResultLatent autoimmune diabetes of the adult: current knowledge and uncertainty
Laugesen, E., Østergaard, J. A., Leslie, R. D. G., & the Danish Diabetes Academy Workshop and Workshop Speakers (2015) · Diabetic Medicine · doi:10.1111/dme.12700 · Cited by 164
Phillips, C. M., Kesse-Guyot, E., McManus, R., Hercberg, S., Lairon, D., Planells, R., & Roche, H. M. (2012) · The Journal of Nutrition · doi:10.3945/jn.111.153460 · Cited by 167
“Recently, we reported novel modulation of MetS risk conferred by the TCF7L2 genotype by dietary SFA (39).”
BackgroundInfluentialWnt/β-Catenin Signaling and Obesity
Chen, N., & Wang, J. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00792 · Cited by 163
Wnt signaling: relevance to β-cell biology and diabetes
Welters, H. J., & Kulkarni, R. N. (2008) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2008.08.004 · Cited by 167
Ahlqvist, E., Ahluwalia, T. S., & Groop, L. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.157016 · Cited by 166
Isolated populations and complex disease gene identification
Kristiansson, K., Naukkarinen, J., & Peltonen, L. (2008) · Genome Biology · doi:10.1186/gb-2008-9-8-109 · Cited by 167
“CDKAL1) [9,10], atrial fibrillation (4q25) [11] and prostate”
Background
Metadata
- Authors
- Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., Styrkarsdottir, U., Magnusson, K. P., Walters, G. B., Palsdottir, E., Jonsdottir, T., Gudmundsdottir, T., Gylfason, A., Saemundsdottir, J., Wilensky, R. L., Reilly, M. P., Rader, D. J., Bagger, Y., Christiansen, C., Gudnason, V., Sigurdsson, G., Thorsteinsdottir, U., Gulcher, J. R., Kong, A., & Stefansson, K.
- Affiliations
- deCODE Genetics (Iceland) (IS)
- National University Hospital of Iceland (IS)
- University of Pennsylvania (US)
- Center for Clinical & Basic Research (DK)
- Icelandic Heart Association (IS)
- Corresponding author
- Grant, Struan F A
- ORCID
- Venue
- Nature Genetics
- Published
- 2006-01-15
- Volume
- 38
- Issue
- 3
- Pages
- 320-323
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1965141016
- Cited by
- 2,287
- References
- 25
- Citations by year
- 2026: 45 · 2025: 58 · 2024: 54 · 2023: 56 · 2022: 80 · 2021: 86 · 2020: 76 · 2019: 86 · 2018: 86 · 2017: 85 · 2016: 99 · 2015: 109 · 2014: 125 · 2013: 125 · 2012: 156
- FWCI
- 127.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Hirsla (Landspítali University Hospital) (submittedVersion)
- Funders
- University of Pennsylvania
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- type 2 diabetes, TCF7L2, transcription factor 7-like 2, chromosome 10q, genetic susceptibility, blood glucose homeostasis, Wnt signaling, Icelandic population, Danish population, United States population
- MeSH terms
- Chromosome Mapping, Chromosomes, Human, Pair 10, Denmark, Diabetes Mellitus, Type 2, Gene Frequency, Genetic Carrier Screening, Humans, Introns, Molecular Sequence Data, Reference Values, Cohort Studies, Microsatellite Repeats, Genetic Predisposition to Disease, TCF Transcription Factors, Transcription Factor 7-Like 2 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.